Alpha Lipoic Acid (ALA) for Sciatica

Alpha-lipoic acid has genuine randomised trial evidence in diabetic nerve pain and early studies in nerve-root pain — plausible but preliminary for sciatica, where movement and time remain the proven therapies.

Overview

Verdict

Mixed evidence

How It Works

As an antioxidant that regenerates other antioxidants and improves nerve blood flow, ALA reduces oxidative stress in damaged nerve tissue. It has demonstrated nerve-conduction and symptom benefits in neuropathy trials.

Dosing & Protocol

Typical dose

Recommended dose: 600 mg daily, 30 minutes before food
Expected timeframe: 3-5 weeks in neuropathy trials; sciatica-specific response unproven

Protocol

form: Racemic ALA, sometimes combined with gamma-linolenic acid in the radicular pain studies
timing: Morning, 30 minutes before food
duration: 6-8 weeks
titration: Stay at 600 mg; higher oral doses add nausea without benefit
measurement: Leg pain on a 0-10 scale plus a straight-leg-raise or walking-distance check at baseline and week 8
starting dose: 600 mg once daily fasted, often trialled alongside conventional care

Evidence

What the studies say

ALA's strongest evidence is in diabetic peripheral neuropathy, where multiple RCTs (the SYDNEY and NATHAN trials) showed symptom and nerve-function improvements at 600 mg daily. Evidence in radicular/sciatic pain is limited to small preliminary studies — mechanistically reasonable, clinically unproven. Sciatica's natural history (most cases improve in 6-12 weeks) and exercise-based care carry the real evidence, and ALA should not delay proven management or assessment of red flags.

Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferol in Discogenic Sciatica in Young People: A Randomized Clinical Trial

Score: 6/10

2023

rct

n=128

Scaturro D, Vitagliani F, Tomasello S +3 more

This prospective study aims to evaluate the effectiveness of a rehabilitation program combined with the administration of Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferol in the treatment of sciatica due to herniated discs in young patients.

View source

Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized, double-blind, comparative study

Score: 6/10

2008

rct

n=64

Memeo A, Loiero M

Thioctic acid 600 mg/day appears to be at least as effective as ALC in the treatment of sciatic pain caused by a herniated disc and may be associated with an improvement in symptom scores and reduced need for analgesia. However, because of the limited number of patients evaluated and the lack of a placebo control in this trial, further studies are warranted in order to provide more definitive results.

View source

Safety

Caveats

Generally well tolerated; possible nausea or heartburn. Can lower blood sugar — caution alongside diabetes medication.

Less likely to help if

People with significant disc herniation or spinal stenosis causing structural compression, where the mechanism is mechanical rather than metabolic.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.